Brian Woolhoouse, VP and General Manager, Hospital Acute Care at Merck joined us for World Anti-Microbial Resistance Congress USA 2015 to discuss ‘Merck’s Commitment to Infectious Diseases: The Commercialization Challenges of New Antibiotics”.
In this presentation, learn about Merck’s commitment to innovation and leadership in infectious diseases.
Download the presentation to understand more about:
- How Merck is actively addressing the unmet need
- Merck’s focus on antibiotic innovation and discovery across many of the most urgent threats
- Launching Novel IV antibiotics
…and much more!
Get your copy here!
To find out more about the commercialization challenges of new antibiotics, attend World Anti-Microbial Resistance Congress USA 2016, held September 8-9 in Washington, DC.